BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

609 related articles for article (PubMed ID: 17898710)

  • 1. The morally uncomfortable global drug gap.
    Cohen-Kohler JC
    Clin Pharmacol Ther; 2007 Nov; 82(5):610-4. PubMed ID: 17898710
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Access to essential medicines: a Hobbesian social contract approach.
    Ashcroft RE
    Dev World Bioeth; 2005 May; 5(2):121-41. PubMed ID: 15842722
    [TBL] [Abstract][Full Text] [Related]  

  • 3. TRIPS, pharmaceutical patents, and access to essential medicines: a long way from Seattle to Doha.
    't Hoen E
    Chic J Int Law; 2002; 3(1):27-46. PubMed ID: 15709298
    [No Abstract]   [Full Text] [Related]  

  • 4. Gender and medicines: an international public health perspective.
    Baghdadi G
    J Womens Health (Larchmt); 2005; 14(1):82-6. PubMed ID: 15692282
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Essential medicines for the whole world.
    Reidenberg MM
    Clin Pharmacol Ther; 2007 Nov; 82(5):500-3. PubMed ID: 17952105
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Has the implementation of the TRIPS Agreement in Latin America and the Caribbean produced intellectual property legislation that favours public health?
    Oliveira MA; Bermudez JA; Chaves GC; Velásquez G
    Bull World Health Organ; 2004 Nov; 82(11):815-21. PubMed ID: 15640916
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Addressing legal and political barriers to global pharmaceutical access: options for remedying the impact of the Agreement on Trade-Related Aspects of Intellectual Property Rights (TRIPS) and the imposition of TRIPS-plus standards.
    Cohen-Kohler JC; Forman L; Lipkus N
    Health Econ Policy Law; 2008 Jul; 3(Pt 3):229-56. PubMed ID: 18634618
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ensuring access to essential medicines: some economic considerations.
    Maskus KE
    Spec Law Dig Health Care Law; 2003 Jul; (291):9-25. PubMed ID: 15206162
    [No Abstract]   [Full Text] [Related]  

  • 9. GATT and the gap: how to save lives.
    James JS
    AIDS Treat News; 1998 Nov; (No 307):1, 3-6. PubMed ID: 11366123
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Health GAP coalition--new group for international treatment access.
    AIDS Treat News; 1999 Mar; (No 315):5-6. PubMed ID: 11366560
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Access to essential drugs, human rights and global justice.
    Shalev C
    Monash Bioeth Rev; 2004 Jan; 23(1):S56-74. PubMed ID: 15835024
    [No Abstract]   [Full Text] [Related]  

  • 12. International obligations through collective rights: Moving from foreign health assistance to global health governance.
    Meier BM; Fox AM
    Health Hum Rights; 2010 Jun; 12(1):61-72. PubMed ID: 20930254
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Access to essential medicines for children: the world health organization's global response.
    Zucker H; Rägo L
    Clin Pharmacol Ther; 2007 Nov; 82(5):503-5. PubMed ID: 17952106
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Patents and access to drugs in developing countries: an ethical analysis.
    Sterckx S
    Dev World Bioeth; 2004 May; 4(1):58-75. PubMed ID: 15086374
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Africa, access, and patents: moving fast.
    James JS
    AIDS Treat News; 1999 Jul; (No 322):5-8. PubMed ID: 11366567
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New frontier of AIDS activism: international trade rules and global access to medicines. Interview by John S. James.
    Sawyer E
    AIDS Treat News; 1999 Apr; (No 317):1, 5-8. PubMed ID: 11366992
    [TBL] [Abstract][Full Text] [Related]  

  • 17. International AIDS treatment momentum: interview with Paul Boneberg, Global AIDS Action Network. Interview by John S. James.
    Boneberg P
    AIDS Treat News; 1999 Aug; (No 324):1, 4-7. PubMed ID: 11366573
    [TBL] [Abstract][Full Text] [Related]  

  • 18. International assistance and cooperation for access to essential medicines.
    Mok EA
    Health Hum Rights; 2010 Jun; 12(1):73-81. PubMed ID: 20930255
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Patents or patients? Global access to pharmaceuticals and social justice.
    de Wildt G; Khoon CC
    Med Confl Surviv; 2008; 24 Suppl 1():S52-61. PubMed ID: 18771195
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Access to medicines and domestic compulsory licensing: learning from Canada and Thailand.
    Kuek V; Phillips K; Kohler JC
    Glob Public Health; 2011; 6(2):111-24. PubMed ID: 20234967
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 31.